These results suggest that mizagliflozin prevents hippocampal neuronal death, leading to VCI, through an inhibitory action against neuronal SGLT1 in a mouse model of ACAS‐induced vascular dementia, even though mizagliflozin did not improve the increased SGLT1 and IL‐1β gene expressions. The gene discussed is SLC5A1; the disease is vascular dementia.